These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30217053)

  • 1. Natural Peptides in Drug Discovery Targeting Acetylcholinesterase.
    Prasasty V; Radifar M; Istyastono E
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30217053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withanolides: Biologically Active Constituents in the Treatment of Alzheimer's Disease.
    Khan SA; Khan SB; Shah Z; Asiri AM
    Med Chem; 2016; 12(3):238-56. PubMed ID: 26527154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.
    Huang L; Su T; Li X
    Curr Top Med Chem; 2013; 13(15):1864-78. PubMed ID: 23931437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential therapeutic agents against Alzheimer's disease from natural sources.
    Park SY
    Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulators of Acetylcholinesterase Activity: From Alzheimer's Disease to Anti-Cancer Drugs.
    Lazarevic-Pasti T; Leskovac A; Momic T; Petrovic S; Vasic V
    Curr Med Chem; 2017; 24(30):3283-3309. PubMed ID: 28685687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase.
    Ahmed S; Khan ST; Zargaham MK; Khan AU; Khan S; Hussain A; Uddin J; Khan A; Al-Harrasi A
    Biomed Pharmacother; 2021 Jul; 139():111609. PubMed ID: 33915501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
    Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
    BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterisation of acetylcholinesterase inhibitors from Aquilaria subintegra for the treatment of Alzheimer's disease (AD).
    Bahrani H; Mohamad J; Paydar MJ; Rothan HA
    Curr Alzheimer Res; 2014 Feb; 11(2):206-14. PubMed ID: 24479629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous extract of Securidaca longipendunculata Oliv. and Olax subscropioidea inhibits key enzymes (acetylcholinesterase and butyrylcholinesterase) linked with Alzheimer's disease in vitro.
    Saliu JA; Olabiyi AA
    Pharm Biol; 2017 Dec; 55(1):252-257. PubMed ID: 27927065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors.
    Cheng ZQ; Song JL; Zhu K; Zhang J; Jiang CS; Zhang H
    Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30134630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anti-Alzheimer drugs from biodiversity: the role of the natural acetylcholinesterase inhibitors.
    Viegas C; Bolzani Vda S; Barreiro EJ; Fraga CA
    Mini Rev Med Chem; 2005 Oct; 5(10):915-26. PubMed ID: 16250834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).
    McHardy SF; Wang HL; McCowen SV; Valdez MC
    Expert Opin Ther Pat; 2017 Apr; 27(4):455-476. PubMed ID: 27967267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marine Peptides: Bioactivities and Applications.
    Cheung RC; Ng TB; Wong JH
    Mar Drugs; 2015 Jun; 13(7):4006-43. PubMed ID: 26132844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B; Singh N
    Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B
    Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
    Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
    Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Old and new acetylcholinesterase inhibitors for Alzheimer's disease.
    Galimberti D; Scarpini E
    Expert Opin Investig Drugs; 2016 Oct; 25(10):1181-7. PubMed ID: 27459153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?
    Macdonald IR; Rockwood K; Martin E; Darvesh S
    J Alzheimers Dis; 2014; 42(2):379-84. PubMed ID: 24898642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.